Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Molecular Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1107-3756 Online ISSN: 1791-244X
Journal Cover
September-2022 Volume 50 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September-2022 Volume 50 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article Open Access

Synthetic antioxidants from a natural source can overtake the oncogenic stress management system and activate the stress‑sensitized death of KSHV‑infected cancer cells

  • Authors:
    • Piyanki Das
    • Goutam Brahmachari
    • Koustav Chatterjee
    • Tathagata Choudhuri
  • View Affiliations / Copyright

    Affiliations: Department of Biotechnology, Visva‑Bharati, (Central University), Bolpur, West Bengal 731235, India, Department of Chemistry, Visva‑Bharati, (Central University), Bolpur, West Bengal 731235, India
    Copyright: © Das et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 117
    |
    Published online on: July 13, 2022
       https://doi.org/10.3892/ijmm.2022.5173
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Synthetic and modified natural derivatives are reported as potential bioactive compounds and are being used therapeutically against various diseases in a widespread manner nowadays. Cancerous cells exhibit high levels of reactive oxygen species (ROS) internally, and thus successfully manage to sustain themselves and proliferate via antioxidative mechanisms that maintain a redox balance. On this note, various antioxidants are applied as anticancer compounds, which strategically affects the ongoing oncogenic stress management system in both a pro‑ and antioxidative manner, resulting in cancer restriction, as well as sustaining cell proliferation via antioxidative mechanisms that promote cancer progression. Alike non‑viral cancers, viral cancers exhibit varying levels of ROS during different stages of cancer progression. Hence, successful stress balance should be addressed, depending on the cancer cell stress response during the therapeutic management. The application of antioxidants is crucial and needs to be carefully designed in such cases; the respective underlying mechanisms are less understood. The role of antioxidants controlling the varied levels of stress response at different stages of Kaposi's sarcoma‑associated herpes virus malignancy have not been fully reported. Therefore, the present study aimed to analyze the activity of certain antioxidants in KSHV‑infected oncogenic cells. For this purpose, two naturally derived flavonoid‑based antioxidants (theaflavin and novel curcumin derivatives) were selected and tested in different KSHV‑infected cell lines. The findings presented herein demonstrate that these compounds can successfully induce the death of different KSHV‑positive cells and can restrict the growth of KSHV‑infected cell lines restricting viral reactivation by counteracting the oncogenic stress management system.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Figure 8

View References

1 

Yarchoan R and Uldrick TS: HIV-associated cancers and related diseases. N Eng J Med. 378:1029–1041. 2018. View Article : Google Scholar

2 

Stewart A, Chan Carusone S, To K, Schaefer-McDaniel N, Halman M and Grimes R: Causes of death in HIV patients and the evolution of an AIDS hospice: 1988-2008. AIDS Res Treat. 2012:3904062012.PubMed/NCBI

3 

Aneja KK and Yuan Y: Reactivation and lytic replication of Kaposi's sarcoma-associated herpesvirus: An update. Front Microbiol. 8:6132017. View Article : Google Scholar : PubMed/NCBI

4 

Miller G, Heston L, Grogan E, Gradoville L, Rigsby M, Sun R, Shedd D, Kushnaryov VM, Grossberg S and Chang Y: Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells. J Virol. 71:314–324. 1997. View Article : Google Scholar : PubMed/NCBI

5 

Ye F, Zhou F, Bedolla RG, Jones T, Lei X, Kang T, Guadalupe M and Gao SJ: Reactive oxygen species hydrogen peroxide mediates Kaposi's sarcoma-associated herpesvirus reactivation from latency. PLoS Pathog. 7:e10020542011. View Article : Google Scholar : PubMed/NCBI

6 

Li X, Feng J and Sun R: Oxidative stress induces reactivation of Kaposi's sarcoma-associated herpesvirus and death of primary effusion lymphoma cells. J Virol. 85:715–724. 2011. View Article : Google Scholar :

7 

Bottero V, Chakraborty S and Chandran B: Reactive oxygen species are induced by Kaposi's sarcoma-associated herpesvirus early during primary infection of endothelial cells to promote virus entry. J Virol. 87:1733–1749. 2013. View Article : Google Scholar :

8 

Davis DA, Rinderknecht AS, Zoeteweij JP, Aoki Y, Read-Connole EL, Tosato G, Blauvelt A and Yarchoan R: Hypoxia induces lytic replication of Kaposi sarcoma-associated herpesvirus. Blood. 97:3244–3250. 2001. View Article : Google Scholar : PubMed/NCBI

9 

Singh RK, Lamplugh ZL, Lang F, Yuan Y, Lieberman P, You J and Robertson ES: KSHV-encoded LANA protects the cellular replication machinery from hypoxia induced degradation. PLOS Pathogens. 15. pp. e10080252019, View Article : Google Scholar

10 

Granato M, Gilardini Montani MS, Angiolillo C, D'Orazi G, Faggioni A and Cirone M: Cytotoxic drugs activate KSHV lytic cycle in latently infected PEL cells by inducing a moderate ROS increase controlled by HSF1, NRF2 and p62/SQSTM1. Viruses. 11:82018. View Article : Google Scholar

11 

Sharma B: Oxidative stress in HIV patients receiving antiretroviral therapy. Curr HIV Res. 12:13–21. 2014. View Article : Google Scholar : PubMed/NCBI

12 

Saavedra-García P, Roman-Trufero M, Al-Sadah HA, Blighe K, López-Jiménez E, Christoforou M, Penfold L, Capece D, Xiong X, Miao Y, et al: Systems level profiling of chemotherapy-induced stress resolution in cancer cells reveals druggable trade-offs. Proc Natl Acad Sci. 118:e20182291182021. View Article : Google Scholar : PubMed/NCBI

13 

Singh K, Bhori M, Kasu YA, Bhat G and Marar T: Antioxidants as precision weapons in war against cancer chemotherapy induced toxicity - Exploring the armoury of obscurity. Saudi Pharm J. 26:177–190. 2018. View Article : Google Scholar : PubMed/NCBI

14 

Mut-Salud N, Álvarez PJ, Garrido JM, Carrasco E, Aránega A and Rodríguez-Serrano F: Antioxidant intake and antitumor therapy: Toward nutritional recommendations for optimal results. Oxid Med Cell Longev. 2016:67195342016. View Article : Google Scholar

15 

Bouayed J and Bohn T: Exogenous antioxidants--Double-edged swords in cellular redox state: Health beneficial effects at physiologic doses versus deleterious effects at high doses. Oxid Med Cell Longev. 3:228–237. 2010. View Article : Google Scholar : PubMed/NCBI

16 

Brahmachari G and Mandal M: One-pot multicomponent synthesis of a new series of curcumin-derived 4H-pyrans under ambient conditions. J Heterocycl Chem. 57:744–750. 2020. View Article : Google Scholar

17 

Broussard G and Damania B: Regulation of KSHV latency and lytic reactivation. Viruses. 12:10342020. View Article : Google Scholar :

18 

Gam Ze Letova C, Kalt I, Shamay M and Sarid R: Latently KSHV-infected cells promote further establishment of latency upon superinfection with KSHV. Int J Mol Sci. 22:119942021. View Article : Google Scholar : PubMed/NCBI

19 

Raja R, Lata S, Trivedi S and Banerjea AC: Serum deprivation/starvation leads to reactivation of HIV-1 in latently infected monocytes via activating ERK/JNK pathway. Sci Rep. 8:144962018. View Article : Google Scholar : PubMed/NCBI

20 

Iki S, Yokota S, Okabayashi T, Yokosawa N, Nagata K and Fujii N: Serum-dependent expression of promyelocytic leukemia protein suppresses propagation of influenza virus. Virology. 343:106–115. 2005. View Article : Google Scholar : PubMed/NCBI

21 

Palmisano I, Della Chiara G, D'Ambrosio RL, Huichalaf C, Brambilla P, Corbetta S, Riba M, Piccirillo R, Valente S, Casari G, et al: Amino acid starvation induces reactivation of silenced transgenes and latent HIV-1 provirus via down-regulation of histone deacetylase 4 (HDAC4). Proc Natl Acad Sci USA. 109:E2284–E2293. 2012. View Article : Google Scholar : PubMed/NCBI

22 

Kumar A, Mohanty S, Das P, Sahu SK, Rajasubramaniam S and Choudhuri T: 1, 25(OH)2 D3 induces reactivation and death of Kaposi's sarcoma-associated herpesvirus of primary effusion lymphoma cells. Sci Rep. 7:124382017. View Article : Google Scholar : PubMed/NCBI

23 

Mohanty S, Kumar A, Das P, Sahu SK and Choudhuri T: Multi-targeted therapy of everolimus in Kaposi's sarcoma associated herpes virus infected primary effusion lymphoma. Apoptosis. 22:1098–1115. 2017. View Article : Google Scholar : PubMed/NCBI

24 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar

25 

Popoola TD and Awodele O: Interplay between antiretroviral therapy and oxidative stress in HIV seropositive patients. Afr J Med Med Sci. 45:5–21. 2016.PubMed/NCBI

26 

Mandas A, Iorio EL, Congiu MG, Balestrieri C, Mereu A, Cau D, Dessì S and Curreli N: Oxidative imbalance in HIV-1 infected patients treated with antiretroviral therapy. J Biomed Biotechnol. 2009:7495752009. View Article : Google Scholar : PubMed/NCBI

27 

Acosta Davila JA and Hernandez De Los Rios A: An overview of peripheral blood mononuclear cells as a model for immunological research of toxoplasma gondii and other apicomplexan parasites. Front Cell Infect Microbiol. 9:24. 2019. View Article : Google Scholar :

28 

Albini A, Morini M, D'Agostini F, Ferrari N, Campelli F, Arena G, Noonan DM, Pesce C and De Flora S: Inhibition of angiogenesis-driven Kaposi's sarcoma tumor growth in nude mice by oral N-Acetylcysteine. Cancer Res. 61:8171–8178. 2001.PubMed/NCBI

29 

Ma Q, Cavallin LE, Yan B, Zhu S, Duran EM, Wang H, Hale LP, Dong C, Cesarman E, Mesri EA and Goldschmidt-Clermont PJ: Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi's sarcoma. Proc Natl Acad Sci. 106:8683–8688. 2009. View Article : Google Scholar : PubMed/NCBI

30 

Ralph SJ, Rodríguez-Enríquez S, Neuzil J, Saavedra E and Moreno-Sánchez R: The causes of cancer revisited: 'mitochondrial malignancy' and ROS-induced oncogenic transformation-why mitochondria are targets for cancer therapy. Mol Aspects Med. 31:145–170. 2010. View Article : Google Scholar : PubMed/NCBI

31 

Wang CH, Wu SB, Wu YT and Wei YH: Oxidative stress response elicited by mitochondrial dysfunction: Implication in the pathophysiology of aging. Exp Biol Med (Maywood). 238:450–460. 2013. View Article : Google Scholar

32 

Gilardini Montani MS, Santarelli R, Granato M, Gonnella R, Torrisi MR, Faggioni A and Cirone M: EBV reduces autophagy, intracellular ROS and mitochondria to impair monocyte survival and differentiation. Autophagy. 15:652–667. 2019. View Article : Google Scholar :

33 

Balistreri G, Viiliäinen J, Turunen M, Diaz R, Lyly L, Pekkonen P, Rantala J, Ojala K, Sarek G, Teesalu M, et al: Oncogenic herpesvirus utilizes stress-induced cell cycle checkpoints for efficient lytic replication. PLoS Pathog. 12:e10054242016. View Article : Google Scholar : PubMed/NCBI

34 

McGeoch DJ and Davison AJ: The descent of human herpesvirus 8. Semin Cancer Biol. 9:201–209. 1999. View Article : Google Scholar : PubMed/NCBI

35 

Leidal AM, Cyr DP, Hill RJ, Lee PW and McCormick C: Subversion of autophagy by Kaposi's sarcoma-associated herpesvirus impairs oncogene-induced senescence. Cell Host Microbe. 11:167–180. 2012. View Article : Google Scholar : PubMed/NCBI

36 

Vescovo T, Pagni B, Piacentini M, Fimia GM and Antonioli M: Regulation of autophagy in cells infected with oncogenic human viruses and its impact on cancer development. Front Cell Dev Biol. 8:472020. View Article : Google Scholar : PubMed/NCBI

37 

Liang C: Viral FLIPping autophagy for longevity. Cell Host Microbe. 11:101–103. 2012. View Article : Google Scholar : PubMed/NCBI

38 

Granato M, Santarelli R, Filardi M, Gonnella R, Farina A, Torrisi MR, Faggioni A and Cirone M: The activation of KSHV lytic cycle blocks autophagy in PEL cells. Autophagy. 11:1978–1986. 2015. View Article : Google Scholar : PubMed/NCBI

39 

Wen HJ, Yang Z, Zhou Y and Wood C: Enhancement of autophagy during lytic replication by the Kaposi's sarcoma-associated herpesvirus replication and transcription activator. J Virol. 84:7448–7458. 2010. View Article : Google Scholar : PubMed/NCBI

40 

Pattingre S and Levine B: Bcl-2 inhibition of autophagy: A new route to cancer? Cancer Res. 66:2885–2888. 2006. View Article : Google Scholar : PubMed/NCBI

41 

Ciechomska IA, Goemans GC, Skepper JN and Tolkovsky AM: Bcl-2 complexed with Beclin-1 maintains full anti-apoptotic function. Oncogene. 28:2128–2141. 2009. View Article : Google Scholar : PubMed/NCBI

42 

Yang B, Liu Q and Bi Y: Autophagy and apoptosis are regulated by stress on Bcl2 by AMBRA1 in the endoplasmic reticulum and mitochondria. Theor Biol Med Model. 16:182019. View Article : Google Scholar : PubMed/NCBI

43 

Qu Y, Wang X, Zhu Y, Wang W, Wang Y, Hu G, Liu C, Li J, Ren S, Xiao MZ, et al: ORF3a-mediated incomplete autophagy facilitates severe acute respiratory syndrome coronavirus-2 replication. Front Cell Dev Biol. 9:7162082021. View Article : Google Scholar : PubMed/NCBI

44 

Yousefi S, Perozzo R, Schmid I, Ziemiecki A, Schaffner T, Scapozza L, Brunner T and Simon HU: Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis. Nat Cell Biol. 8:1124–1132. 2006. View Article : Google Scholar : PubMed/NCBI

45 

Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV, Dawson TM, Dawson VL, El-Deiry WS, Fulda S, et al: Molecular definitions of cell death subroutines: Recommendations of the nomenclature committee on cell death. 2012.Cell Death Differ. 19:107–120. 2012. View Article : Google Scholar

46 

Paquette M, El-Houjeiri L and Pause A: mTOR pathways in cancer and autophagy. Cancers (Basel). 10:182018. View Article : Google Scholar

47 

Zhang J, Gao Z and Ye J: Phosphorylation and degradation of S6K1 (p70S6K1) in response to persistent JNK1 activation. Biochim Biophys Acta. 1832:1980–1988. 2013. View Article : Google Scholar : PubMed/NCBI

48 

Nichols LA, Adang LA and Kedes DH: Rapamycin blocks production of KSHV/HHV8: Insights into the anti-tumor activity of an immunosuppressant drug. PLoS One. 6:e145352011. View Article : Google Scholar : PubMed/NCBI

49 

O'Neill EJ, Termini D, Albano A and Tsiani E: Anti-cancer properties of theaflavins. Molecules. 26:9872021. View Article : Google Scholar : PubMed/NCBI

50 

Kuo CJ, Huang CC, Chou SY, Lo YC, Kao TJ, Huang NK, Lin C, Lin HC, Lin HC and Lee YC: Potential therapeutic effect of curcumin, a natural mTOR inhibitor, in tuberous sclerosis complex. Phytomedicine. 54:132–139. 2019. View Article : Google Scholar : PubMed/NCBI

51 

Beevers CS, Zhou H and Huang S: Hitting the golden TORget: Curcumin's effects on mTOR signaling. Anticancer Agents Med Chem. 13:988–994. 2013. View Article : Google Scholar : PubMed/NCBI

52 

Kopustinskiene DM, Jakstas V, Savickas A and Bernatoniene J: Flavonoids as anticancer agents. Nutrients. 12:4572020. View Article : Google Scholar :

53 

Liou GY and Storz P: Reactive oxygen species in cancer. Free Radic Res. 44:479–496. 2010. View Article : Google Scholar : PubMed/NCBI

54 

Tomeh MA, Hadianamrei R and Zhao X: A review of curcumin and its derivatives as anticancer agents. Int J Mol Sci. 20:10332019. View Article : Google Scholar :

55 

Uddin S, Hussain AR, Manogaran PS, Al-Hussein K, Platanias LC, Gutierrez MI and Bhatia KG: Curcumin suppresses growth and induces apoptosis in primary effusion lymphoma. Oncogene. 24:7022–7030. 2005. View Article : Google Scholar : PubMed/NCBI

56 

Zhong C, Xu M, Wang Y, Xu J and Yuan Y: An APE1 inhibitor reveals critical roles of the redox function of APE1 in KSHV replication and pathogenic phenotypes. PLoS Pathog. 13:e10062892017. View Article : Google Scholar : PubMed/NCBI

57 

Li H, Zhong C, Wang Q, Chen W and Yuan Y: Curcumin is an APE1 redox inhibitor and exhibits an antiviral activity against KSHV replication and pathogenesis. Antiviral Res. 167:98–103. 2019. View Article : Google Scholar : PubMed/NCBI

58 

Stone WL, Krishnan K, Campbell SE and Palau VE: The role of antioxidants and pro-oxidants in colon cancer. World J Gastrointest Oncol. 6:55–66. 2014. View Article : Google Scholar : PubMed/NCBI

59 

Gerhardt T, Jones R, Park J, Lu R, Chan HW, Fang Q, Singh N and Lai H: Effects of antioxidants and pro-oxidants on cytotoxicity of dihydroartemisinin to molt-4 human leukemia cells. Anticancer Res. 35:18672015.PubMed/NCBI

60 

Adhikary A, Mohanty S, Lahiry L, Hossain DMS, Chakraborty S and Das T: Theaflavins retard human breast cancer cell migration by inhibiting NF-κB via p53-ROS cross-talk. FEBS Lett. 584:7–14. 2010. View Article : Google Scholar

61 

Kumar Singh R, Pei Y, Bose D, Lamplugh ZL, Sun K, Yuan Y, Lieberman P, You J and Robertson ES: KSHV-encoded vCyclin can modulate HIF1α levels to promote DNA replication in hypoxia. Elife. 10:e574362021. View Article : Google Scholar

62 

Das P, Roy Chattopadhyay N, Chatterjee K and Choudhuri T: Kaposi's sarcoma-associated herpesvirus related malignancy in India, a rare but emerging member to be considered. VirusDisease. 31:209–219. 2020. View Article : Google Scholar : PubMed/NCBI

63 

Tasca KI, Caleffi JT, Correa CR, Gatto M, Tavares FC, Camargo CC, Sartori A, Biasin M and de Souza LD: Antiretroviral therapy initiation alters the redox system of asymptomatic HIV-infected individuals: A longitudinal study. Oxid Med Cell Longev. 2017:98348032017. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Das P, Brahmachari G, Chatterjee K and Choudhuri T: Synthetic antioxidants from a natural source can overtake the oncogenic stress management system and activate the stress‑sensitized death of KSHV‑infected cancer cells. Int J Mol Med 50: 117, 2022.
APA
Das, P., Brahmachari, G., Chatterjee, K., & Choudhuri, T. (2022). Synthetic antioxidants from a natural source can overtake the oncogenic stress management system and activate the stress‑sensitized death of KSHV‑infected cancer cells. International Journal of Molecular Medicine, 50, 117. https://doi.org/10.3892/ijmm.2022.5173
MLA
Das, P., Brahmachari, G., Chatterjee, K., Choudhuri, T."Synthetic antioxidants from a natural source can overtake the oncogenic stress management system and activate the stress‑sensitized death of KSHV‑infected cancer cells". International Journal of Molecular Medicine 50.3 (2022): 117.
Chicago
Das, P., Brahmachari, G., Chatterjee, K., Choudhuri, T."Synthetic antioxidants from a natural source can overtake the oncogenic stress management system and activate the stress‑sensitized death of KSHV‑infected cancer cells". International Journal of Molecular Medicine 50, no. 3 (2022): 117. https://doi.org/10.3892/ijmm.2022.5173
Copy and paste a formatted citation
x
Spandidos Publications style
Das P, Brahmachari G, Chatterjee K and Choudhuri T: Synthetic antioxidants from a natural source can overtake the oncogenic stress management system and activate the stress‑sensitized death of KSHV‑infected cancer cells. Int J Mol Med 50: 117, 2022.
APA
Das, P., Brahmachari, G., Chatterjee, K., & Choudhuri, T. (2022). Synthetic antioxidants from a natural source can overtake the oncogenic stress management system and activate the stress‑sensitized death of KSHV‑infected cancer cells. International Journal of Molecular Medicine, 50, 117. https://doi.org/10.3892/ijmm.2022.5173
MLA
Das, P., Brahmachari, G., Chatterjee, K., Choudhuri, T."Synthetic antioxidants from a natural source can overtake the oncogenic stress management system and activate the stress‑sensitized death of KSHV‑infected cancer cells". International Journal of Molecular Medicine 50.3 (2022): 117.
Chicago
Das, P., Brahmachari, G., Chatterjee, K., Choudhuri, T."Synthetic antioxidants from a natural source can overtake the oncogenic stress management system and activate the stress‑sensitized death of KSHV‑infected cancer cells". International Journal of Molecular Medicine 50, no. 3 (2022): 117. https://doi.org/10.3892/ijmm.2022.5173
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team